<Disease><Name>NEUROBLASTOMA, SUSCEPTIBILITY TO</Name><Synonym>NEUROBLASTOMA</Synonym><OMIM><Number>256700</Number><URL>http://omim.org/entry/256700</URL></OMIM><Orphanet><Number>635</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=635</URL></Orphanet><Protein><Number>Kinesin-like protein KIF1B</Number><URL>http://www.uniprot.org/uniprot/O60333</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>17q21.32, 1p36.22</Gene><ICD>C74.9</ICD><Summary>rare;autosomal dominant;mutations in the KIF1B gene</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1713</id><symptom>fever, severe or recurrent</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>2358</id><symptom>pain, bones or joints / pain bones</symptom><category>GENERAL TOPICS | SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1702</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>3.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>669</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>increased</value><min>3.10</min><max>21.80</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>671</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>increased</value><min>1.30</min><max>11.50</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>670</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>increased</value><min>12.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>672</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>13.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>673</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>912</id><name>Dopamine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>906</id><name>Dopamine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit /><age>no data</age><method /><comment /></metabolite><metabolite><id>913</id><name>Dopamine</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4866</id><title>Clinical research on rare diseases of children: neuroblastoma</title><author>Gerardi C,</author><journal>Cancer Chemother Pharmacol</journal><year>2017</year><book /><volume>79</volume><number>2</number><pages>267-273</pages><co_aut>et al.</co_aut></literature><literature><id>4865</id><title>Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology</title><author>Salazar BM,</author><journal>Int J Mol Sci</journal><year>2016</year><book /><volume>18</volume><number>1</number><pages>e37</pages><co_aut>et al.</co_aut></literature><literature><id>4867</id><title>Neuroblastoma</title><author>Schulte JH,</author><journal>Crit Rev Oncog</journal><year>2015</year><book /><volume>20</volume><number>3</number><pages>245-270</pages><co_aut>Eggert A</co_aut></literature></Literatures></Disease>